Clinical Trial Detail

NCT ID NCT02266147
Title Study of SD-101 in Combination With Localized Low-dose Radiation in Patients With Untreated Low-grade B-cell Lymphoma
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Dynavax Technologies Corporation
Indications

follicular lymphoma

marginal zone B-cell lymphoma

B-cell lymphoma

CLL/SLL

Therapies

SD-101

Age Groups: adult

No variant requirements are available.